APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Basal Insulin (Long-Acting Insulin)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Basal Insulin (Long-Acting Insulin) Market Analysis and Forecast 2026-2032

Report ID 173969290220 December 2025193 pages

Choose your research edition.

Industry ResearchBasal Insulin (Long-Acting Insulin) Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Basal Insulin (Long-Acting Insulin) Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Basal Insulin (Long-Acting Insulin) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Basal Insulin (Long-Acting Insulin) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Basal Insulin (Long-Acting Insulin) Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Basal Insulin (Long-Acting Insulin) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Basal Insulin (Long-Acting Insulin) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Basal Insulin (Long-Acting Insulin) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Basal Insulin (Long-Acting Insulin) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Basal Insulin (Long-Acting Insulin) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Basal Insulin (Long-Acting Insulin) include Wockhardt, Eli Lilly, Julphar, Sedico, Sanofi Aventis, Novo Nordisk, Exir and Biocon, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Basal Insulin (Long-Acting Insulin), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Basal Insulin (Long-Acting Insulin), also provides the sales of main regions and countries. Of the upcoming market potential for Basal Insulin (Long-Acting Insulin), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Basal Insulin (Long-Acting Insulin) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Basal Insulin (Long-Acting Insulin) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Basal Insulin (Long-Acting Insulin) sales, projected growth trends, production technology, application and end-user industry.

Basal Insulin (Long-Acting Insulin) Segment by Company

Wockhardt

Eli Lilly

Julphar

Sedico

Sanofi Aventis

Novo Nordisk

Exir

Biocon

Basal Insulin (Long-Acting Insulin) Segment by Type

Basaglar

Lantus

Levemir

Biosimilar Glargines

Toujeo

Tresiba

Basal Insulin (Long-Acting Insulin) Segment by Application

Type 1 Diabetes

Type 2 Diabetes

Basal Insulin (Long-Acting Insulin) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Basal Insulin (Long-Acting Insulin) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Basal Insulin (Long-Acting Insulin) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Basal Insulin (Long-Acting Insulin).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Basal Insulin (Long-Acting Insulin) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Basal Insulin (Long-Acting Insulin) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Basal Insulin (Long-Acting Insulin) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Basal Insulin (Long-Acting Insulin) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Basaglar Major Manufacturers Table 3. Lantus Major Manufacturers Table 4. Levemir Major Manufacturers Table 5. Biosimilar Glargines Major Manufacturers Table 6. Toujeo Major Manufacturers Table 7. Tresiba Major Manufacturers Table 8. Global Basal Insulin (Long-Acting Insulin) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Type 1 Diabetes Major Manufacturers Table 10. Type 2 Diabetes Major Manufacturers Table 11. Basal Insulin (Long-Acting Insulin) Industry Trends Table 12. Basal Insulin (Long-Acting Insulin) Industry Drivers Table 13. Basal Insulin (Long-Acting Insulin) Industry Opportunities and Challenges Table 14. Basal Insulin (Long-Acting Insulin) Industry Restraints Table 15. Global Basal Insulin (Long-Acting Insulin) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2021-2026) Table 19. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2027-2032) Table 20. Global Basal Insulin (Long-Acting Insulin) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2021-2026) & (K Units) Table 22. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2027-2032) & (K Units) Table 23. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2021-2026) Table 24. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2027-2032) Table 25. Global Basal Insulin (Long-Acting Insulin) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Basal Insulin (Long-Acting Insulin) Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Manufacturers (2021-2026) Table 29. Global Basal Insulin (Long-Acting Insulin) Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Basal Insulin (Long-Acting Insulin) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Basal Insulin (Long-Acting Insulin) Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Basal Insulin (Long-Acting Insulin) Manufacturers, Product Type & Application Table 33. Global Basal Insulin (Long-Acting Insulin) Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Basal Insulin (Long-Acting Insulin) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Basal Insulin (Long-Acting Insulin) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2021-2026) Table 40. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2027-2032) Table 41. Global Basal Insulin (Long-Acting Insulin) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2021-2026) & (K Units) Table 43. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2027-2032) & (K Units) Table 44. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2021-2026) Table 45. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2027-2032) Table 46. Global Basal Insulin (Long-Acting Insulin) Price by Type (2021-2026) & (US$/Unit) Table 47. Global Basal Insulin (Long-Acting Insulin) Price by Type (2027-2032) & (US$/Unit) Table 48. Global Basal Insulin (Long-Acting Insulin) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2021-2026) Table 52. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2027-2032) Table 53. Global Basal Insulin (Long-Acting Insulin) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2021-2026) & (K Units) Table 55. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2027-2032) & (K Units) Table 56. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2021-2026) Table 57. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2027-2032) Table 58. Global Basal Insulin (Long-Acting Insulin) Price by Application (2021-2026) & (US$/Unit) Table 59. Global Basal Insulin (Long-Acting Insulin) Price by Application (2027-2032) & (US$/Unit) Table 60. Wockhardt Company Information Table 61. Wockhardt Business Overview Table 62. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Wockhardt Basal Insulin (Long-Acting Insulin) Product Portfolio Table 64. Wockhardt Recent Development Table 65. Eli Lilly Company Information Table 66. Eli Lilly Business Overview Table 67. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Eli Lilly Basal Insulin (Long-Acting Insulin) Product Portfolio Table 69. Eli Lilly Recent Development Table 70. Julphar Company Information Table 71. Julphar Business Overview Table 72. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Julphar Basal Insulin (Long-Acting Insulin) Product Portfolio Table 74. Julphar Recent Development Table 75. Sedico Company Information Table 76. Sedico Business Overview Table 77. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Sedico Basal Insulin (Long-Acting Insulin) Product Portfolio Table 79. Sedico Recent Development Table 80. Sanofi Aventis Company Information Table 81. Sanofi Aventis Business Overview Table 82. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Portfolio Table 84. Sanofi Aventis Recent Development Table 85. Novo Nordisk Company Information Table 86. Novo Nordisk Business Overview Table 87. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Portfolio Table 89. Novo Nordisk Recent Development Table 90. Exir Company Information Table 91. Exir Business Overview Table 92. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Exir Basal Insulin (Long-Acting Insulin) Product Portfolio Table 94. Exir Recent Development Table 95. Biocon Company Information Table 96. Biocon Business Overview Table 97. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Biocon Basal Insulin (Long-Acting Insulin) Product Portfolio Table 99. Biocon Recent Development Table 100. North America Basal Insulin (Long-Acting Insulin) Revenue by Type (2021-2026) & (US$ Million) Table 101. North America Basal Insulin (Long-Acting Insulin) Revenue by Type (2027-2032) & (US$ Million) Table 102. North America Basal Insulin (Long-Acting Insulin) Sales by Type (2021-2026) & (K Units) Table 103. North America Basal Insulin (Long-Acting Insulin) Sales by Type (2027-2032) & (K Units) Table 104. North America Basal Insulin (Long-Acting Insulin) Sales Price by Type (2021-2026) & (US$/Unit) Table 105. North America Basal Insulin (Long-Acting Insulin) Sales Price by Type (2027-2032) & (US$/Unit) Table 106. North America Basal Insulin (Long-Acting Insulin) Revenue by Application (2021-2026) & (US$ Million) Table 107. North America Basal Insulin (Long-Acting Insulin) Revenue by Application (2027-2032) & (US$ Million) Table 108. North America Basal Insulin (Long-Acting Insulin) Sales by Application (2021-2026) & (K Units) Table 109. North America Basal Insulin (Long-Acting Insulin) Sales by Application (2027-2032) & (K Units) Table 110. North America Basal Insulin (Long-Acting Insulin) Sales Price by Application (2021-2026) & (US$/Unit) Table 111. North America Basal Insulin (Long-Acting Insulin) Sales Price by Application (2027-2032) & (US$/Unit) Table 112. North America Basal Insulin (Long-Acting Insulin) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. North America Basal Insulin (Long-Acting Insulin) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 114. North America Basal Insulin (Long-Acting Insulin) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 115. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 116. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2021-2026) & (K Units) Table 117. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2027-2032) & (K Units) Table 118. North America Basal Insulin (Long-Acting Insulin) Sales Price by Country (2021-2026) & (US$/Unit) Table 119. North America Basal Insulin (Long-Acting Insulin) Sales Price by Country (2027-2032) & (US$/Unit) Table 120. United States Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 121. Canada Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 122. Europe Basal Insulin (Long-Acting Insulin) Revenue by Type (2021-2026) & (US$ Million) Table 123. Europe Basal Insulin (Long-Acting Insulin) Revenue by Type (2027-2032) & (US$ Million) Table 124. Europe Basal Insulin (Long-Acting Insulin) Sales by Type (2021-2026) & (K Units) Table 125. Europe Basal Insulin (Long-Acting Insulin) Sales by Type (2027-2032) & (K Units) Table 126. Europe Basal Insulin (Long-Acting Insulin) Sales Price by Type (2021-2026) & (US$/Unit) Table 127. Europe Basal Insulin (Long-Acting Insulin) Sales Price by Type (2027-2032) & (US$/Unit) Table 128. Europe Basal Insulin (Long-Acting Insulin) Revenue by Application (2021-2026) & (US$ Million) Table 129. Europe Basal Insulin (Long-Acting Insulin) Revenue by Application (2027-2032) & (US$ Million) Table 130. Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2021-2026) & (K Units) Table 131. Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2027-2032) & (K Units) Table 132. Europe Basal Insulin (Long-Acting Insulin) Sales Price by Application (2021-2026) & (US$/Unit) Table 133. Europe Basal Insulin (Long-Acting Insulin) Sales Price by Application (2027-2032) & (US$/Unit) Table 134. Europe Basal Insulin (Long-Acting Insulin) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Europe Basal Insulin (Long-Acting Insulin) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. Europe Basal Insulin (Long-Acting Insulin) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 138. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2021-2026) & (K Units) Table 139. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2027-2032) & (K Units) Table 140. Europe Basal Insulin (Long-Acting Insulin) Sales Price by Country (2021-2026) & (US$/Unit) Table 141. Europe Basal Insulin (Long-Acting Insulin) Sales Price by Country (2027-2032) & (US$/Unit) Table 142. Germany Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 143. France Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 144. U.K. Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 145. Italy Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 146. Netherlands Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 147. China Basal Insulin (Long-Acting Insulin) Revenue by Type (2021-2026) & (US$ Million) Table 148. China Basal Insulin (Long-Acting Insulin) Revenue by Type (2027-2032) & (US$ Million) Table 149. China Basal Insulin (Long-Acting Insulin) Sales by Type (2021-2026) & (K Units) Table 150. China Basal Insulin (Long-Acting Insulin) Sales by Type (2027-2032) & (K Units) Table 151. China Basal Insulin (Long-Acting Insulin) Sales Price by Type (2021-2026) & (US$/Unit) Table 152. China Basal Insulin (Long-Acting Insulin) Sales Price by Type (2027-2032) & (US$/Unit) Table 153. China Basal Insulin (Long-Acting Insulin) Revenue by Application (2021-2026) & (US$ Million) Table 154. China Basal Insulin (Long-Acting Insulin) Revenue by Application (2027-2032) & (US$ Million) Table 155. China Basal Insulin (Long-Acting Insulin) Sales by Application (2021-2026) & (K Units) Table 156. China Basal Insulin (Long-Acting Insulin) Sales by Application (2027-2032) & (K Units) Table 157. China Basal Insulin (Long-Acting Insulin) Sales Price by Application (2021-2026) & (US$/Unit) Table 158. China Basal Insulin (Long-Acting Insulin) Sales Price by Application (2027-2032) & (US$/Unit) Table 159. Asia Basal Insulin (Long-Acting Insulin) Revenue by Type (2021-2026) & (US$ Million) Table 160. Asia Basal Insulin (Long-Acting Insulin) Revenue by Type (2027-2032) & (US$ Million) Table 161. Asia Basal Insulin (Long-Acting Insulin) Sales by Type (2021-2026) & (K Units) Table 162. Asia Basal Insulin (Long-Acting Insulin) Sales by Type (2027-2032) & (K Units) Table 163. Asia Basal Insulin (Long-Acting Insulin) Sales Price by Type (2021-2026) & (US$/Unit) Table 164. Asia Basal Insulin (Long-Acting Insulin) Sales Price by Type (2027-2032) & (US$/Unit) Table 165. Asia Basal Insulin (Long-Acting Insulin) Revenue by Application (2021-2026) & (US$ Million) Table 166. Asia Basal Insulin (Long-Acting Insulin) Revenue by Application (2027-2032) & (US$ Million) Table 167. Asia Basal Insulin (Long-Acting Insulin) Sales by Application (2021-2026) & (K Units) Table 168. Asia Basal Insulin (Long-Acting Insulin) Sales by Application (2027-2032) & (K Units) Table 169. Asia Basal Insulin (Long-Acting Insulin) Sales Price by Application (2021-2026) & (US$/Unit) Table 170. Asia Basal Insulin (Long-Acting Insulin) Sales Price by Application (2027-2032) & (US$/Unit) Table 171. Asia Basal Insulin (Long-Acting Insulin) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Asia Basal Insulin (Long-Acting Insulin) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. Asia Basal Insulin (Long-Acting Insulin) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. Asia Basal Insulin (Long-Acting Insulin) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 175. Asia Basal Insulin (Long-Acting Insulin) Sales by Country (2021-2026) & (K Units) Table 176. Asia Basal Insulin (Long-Acting Insulin) Sales by Country (2027-2032) & (K Units) Table 177. Asia Basal Insulin (Long-Acting Insulin) Sales Price by Country (2021-2026) & (US$/Unit) Table 178. Asia Basal Insulin (Long-Acting Insulin) Sales Price by Country (2027-2032) & (US$/Unit) Table 179. Japan Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 180. South Korea Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 181. India Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 182. Australia Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 183. China Taiwan Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 184. Southeast Asia Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 185. SAMEA Basal Insulin (Long-Acting Insulin) Revenue by Type (2021-2026) & (US$ Million) Table 186. SAMEA Basal Insulin (Long-Acting Insulin) Revenue by Type (2027-2032) & (US$ Million) Table 187. SAMEA Basal Insulin (Long-Acting Insulin) Sales by Type (2021-2026) & (K Units) Table 188. SAMEA Basal Insulin (Long-Acting Insulin) Sales by Type (2027-2032) & (K Units) Table 189. SAMEA Basal Insulin (Long-Acting Insulin) Sales Price by Type (2021-2026) & (US$/Unit) Table 190. SAMEA Basal Insulin (Long-Acting Insulin) Sales Price by Type (2027-2032) & (US$/Unit) Table 191. SAMEA Basal Insulin (Long-Acting Insulin) Revenue by Application (2021-2026) & (US$ Million) Table 192. SAMEA Basal Insulin (Long-Acting Insulin) Revenue by Application (2027-2032) & (US$ Million) Table 193. SAMEA Basal Insulin (Long-Acting Insulin) Sales by Application (2021-2026) & (K Units) Table 194. SAMEA Basal Insulin (Long-Acting Insulin) Sales by Application (2027-2032) & (K Units) Table 195. SAMEA Basal Insulin (Long-Acting Insulin) Sales Price by Application (2021-2026) & (US$/Unit) Table 196. SAMEA Basal Insulin (Long-Acting Insulin) Sales Price by Application (2027-2032) & (US$/Unit) Table 197. SAMEA Basal Insulin (Long-Acting Insulin) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 198. SAMEA Basal Insulin (Long-Acting Insulin) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 199. SAMEA Basal Insulin (Long-Acting Insulin) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 200. SAMEA Basal Insulin (Long-Acting Insulin) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 201. SAMEA Basal Insulin (Long-Acting Insulin) Sales by Country (2021-2026) & (K Units) Table 202. SAMEA Basal Insulin (Long-Acting Insulin) Sales by Country (2027-2032) & (K Units) Table 203. SAMEA Basal Insulin (Long-Acting Insulin) Sales Price by Country (2021-2026) & (US$/Unit) Table 204. SAMEA Basal Insulin (Long-Acting Insulin) Sales Price by Country (2027-2032) & (US$/Unit) Table 205. Brazil Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 206. Argentina Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 207. Chile Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 208. Colombia Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 209. Peru Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 210. Saudi Arabia Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 211. Israel Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 212. UAE Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 213. Turkey Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 214. Iran Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 215. Egypt Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Basal Insulin (Long-Acting Insulin) Distributors List Table 219. Basal Insulin (Long-Acting Insulin) Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Basal Insulin (Long-Acting Insulin) Image Figure 2. Global Basal Insulin (Long-Acting Insulin) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Basal Insulin (Long-Acting Insulin) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Basaglar Image Figure 5. Lantus Image Figure 6. Levemir Image Figure 7. Biosimilar Glargines Image Figure 8. Toujeo Image Figure 9. Tresiba Image Figure 10. Global Basal Insulin (Long-Acting Insulin) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Basal Insulin (Long-Acting Insulin) Market Size Share 2021 VS 2025 VS 2032 Figure 12. Type 1 Diabetes Image Figure 13. Type 2 Diabetes Image Figure 14. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Figure 16. Global Basal Insulin (Long-Acting Insulin) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2021-2032) Figure 19. Global Basal Insulin (Long-Acting Insulin) Sales (2021-2032) & (K Units) Figure 20. Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Basal Insulin (Long-Acting Insulin) Sales YoY (2021-2032) & (K Units) Figure 23. Europe Basal Insulin (Long-Acting Insulin) Sales YoY (2021-2032) & (K Units) Figure 24. China Basal Insulin (Long-Acting Insulin) Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Basal Insulin (Long-Acting Insulin) Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales YoY (2021-2032) & (K Units) Figure 27. Global Basal Insulin (Long-Acting Insulin) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Basal Insulin (Long-Acting Insulin) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2021-2032) Figure 33. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2021-2032) Figure 36. Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2021-2032) Figure 39. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2021-2032) Figure 42. North America Basal Insulin (Long-Acting Insulin) Revenue Share by Type (2021-2032) Figure 43. North America Basal Insulin (Long-Acting Insulin) Sales Share by Type (2021-2032) Figure 44. North America Basal Insulin (Long-Acting Insulin) Revenue Share by Application (2021-2032) Figure 45. North America Basal Insulin (Long-Acting Insulin) Sales Share by Application (2021-2032) Figure 46. North America Basal Insulin (Long-Acting Insulin) Revenue Share by Country (2021-2032) Figure 47. North America Basal Insulin (Long-Acting Insulin) Sales Share by Country (2021-2032) Figure 48. Europe Basal Insulin (Long-Acting Insulin) Revenue Share by Type (2021-2032) Figure 49. Europe Basal Insulin (Long-Acting Insulin) Sales Share by Type (2021-2032) Figure 50. Europe Basal Insulin (Long-Acting Insulin) Revenue Share by Application (2021-2032) Figure 51. Europe Basal Insulin (Long-Acting Insulin) Sales Share by Application (2021-2032) Figure 52. Europe Basal Insulin (Long-Acting Insulin) Revenue Share by Country (2021-2032) Figure 53. Europe Basal Insulin (Long-Acting Insulin) Sales Share by Country (2021-2032) Figure 54. China Basal Insulin (Long-Acting Insulin) Revenue Share by Type (2021-2032) Figure 55. China Basal Insulin (Long-Acting Insulin) Sales Share by Type (2021-2032) Figure 56. China Basal Insulin (Long-Acting Insulin) Revenue Share by Application (2021-2032) Figure 57. China Basal Insulin (Long-Acting Insulin) Sales Share by Application (2021-2032) Figure 58. Asia Basal Insulin (Long-Acting Insulin) Revenue Share by Type (2021-2032) Figure 59. Asia Basal Insulin (Long-Acting Insulin) Sales Share by Type (2021-2032) Figure 60. Asia Basal Insulin (Long-Acting Insulin) Revenue Share by Application (2021-2032) Figure 61. Asia Basal Insulin (Long-Acting Insulin) Sales Share by Application (2021-2032) Figure 62. Asia Basal Insulin (Long-Acting Insulin) Revenue Share by Country (2021-2032) Figure 63. Asia Basal Insulin (Long-Acting Insulin) Sales Share by Country (2021-2032) Figure 64. SAMEA Basal Insulin (Long-Acting Insulin) Revenue Share by Type (2021-2032) Figure 65. SAMEA Basal Insulin (Long-Acting Insulin) Sales Share by Type (2021-2032) Figure 66. SAMEA Basal Insulin (Long-Acting Insulin) Revenue Share by Application (2021-2032) Figure 67. SAMEA Basal Insulin (Long-Acting Insulin) Sales Share by Application (2021-2032) Figure 68. SAMEA Basal Insulin (Long-Acting Insulin) Revenue Share by Country (2021-2032) Figure 69. SAMEA Basal Insulin (Long-Acting Insulin) Sales Share by Country (2021-2032) Figure 70. Basal Insulin (Long-Acting Insulin) Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Basal Insulin (Long-Acting Insulin) Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Basaglar
  • Lantus
  • Levemir
  • Biosimilar Glargines
  • Toujeo
  • Tresiba
Applications
  • Type 1 Diabetes
  • Type 2 Diabetes
Companies covered
  • Wockhardt
  • Eli Lilly
  • Julphar
  • Sedico
  • Sanofi Aventis
  • Novo Nordisk
  • Exir
  • Biocon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Basal Insulin (Long-Acting Insulin) Market by Type
  3. 1.2.1 Global Basal Insulin (Long-Acting Insulin) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Basaglar
  5. 1.2.3 Lantus
  6. 1.2.4 Levemir
  7. 1.2.5 Biosimilar Glargines
  8. 1.2.6 Toujeo
  9. 1.2.7 Tresiba
  10. 1.3 Basal Insulin (Long-Acting Insulin) Market by Application
  11. 1.3.1 Global Basal Insulin (Long-Acting Insulin) Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Type 1 Diabetes
  13. 1.3.3 Type 2 Diabetes
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Basal Insulin (Long-Acting Insulin) Market Dynamics
  1. 2.1 Basal Insulin (Long-Acting Insulin) Industry Trends
  2. 2.2 Basal Insulin (Long-Acting Insulin) Industry Drivers
  3. 2.3 Basal Insulin (Long-Acting Insulin) Industry Opportunities and Challenges
  4. 2.4 Basal Insulin (Long-Acting Insulin) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Basal Insulin (Long-Acting Insulin) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Region
  3. 3.2.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2021-2026)
  5. 3.2.3 Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2027-2032)
  6. 3.2.4 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Basal Insulin (Long-Acting Insulin) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Basal Insulin (Long-Acting Insulin) Sales by Region
  9. 3.4.1 Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Basal Insulin (Long-Acting Insulin) Sales by Region (2021-2026)
  11. 3.4.3 Global Basal Insulin (Long-Acting Insulin) Sales by Region (2027-2032)
  12. 3.4.4 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Manufacturers
  2. 4.1.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Basal Insulin (Long-Acting Insulin) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Basal Insulin (Long-Acting Insulin) Sales by Manufacturers
  6. 4.2.1 Global Basal Insulin (Long-Acting Insulin) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Basal Insulin (Long-Acting Insulin) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Basal Insulin (Long-Acting Insulin) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Basal Insulin (Long-Acting Insulin) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Basal Insulin (Long-Acting Insulin) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Basal Insulin (Long-Acting Insulin) Manufacturers, Product Type & Application
  13. 4.7 Global Basal Insulin (Long-Acting Insulin) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Basal Insulin (Long-Acting Insulin) Market CR5 and HHI
  16. 4.8.2 2025 Basal Insulin (Long-Acting Insulin) Tier 1, Tier 2, and Tier 3
5 Basal Insulin (Long-Acting Insulin) Market by Type
  1. 5.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Type
  2. 5.1.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Basal Insulin (Long-Acting Insulin) Sales by Type
  6. 5.2.1 Global Basal Insulin (Long-Acting Insulin) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Basal Insulin (Long-Acting Insulin) Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Basal Insulin (Long-Acting Insulin) Price by Type
6 Basal Insulin (Long-Acting Insulin) Market by Application
  1. 6.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Application
  2. 6.1.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Basal Insulin (Long-Acting Insulin) Sales by Application
  6. 6.2.1 Global Basal Insulin (Long-Acting Insulin) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Basal Insulin (Long-Acting Insulin) Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Basal Insulin (Long-Acting Insulin) Price by Application
7 Company Profiles
  1. 7.1 Wockhardt
  2. 7.1.1 Wockhardt Company Information
  3. 7.1.2 Wockhardt Business Overview
  4. 7.1.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Wockhardt Basal Insulin (Long-Acting Insulin) Product Portfolio
  6. 7.1.5 Wockhardt Recent Developments
  7. 7.2 Eli Lilly
  8. 7.2.1 Eli Lilly Company Information
  9. 7.2.2 Eli Lilly Business Overview
  10. 7.2.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eli Lilly Basal Insulin (Long-Acting Insulin) Product Portfolio
  12. 7.2.5 Eli Lilly Recent Developments
  13. 7.3 Julphar
  14. 7.3.1 Julphar Company Information
  15. 7.3.2 Julphar Business Overview
  16. 7.3.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Julphar Basal Insulin (Long-Acting Insulin) Product Portfolio
  18. 7.3.5 Julphar Recent Developments
  19. 7.4 Sedico
  20. 7.4.1 Sedico Company Information
  21. 7.4.2 Sedico Business Overview
  22. 7.4.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sedico Basal Insulin (Long-Acting Insulin) Product Portfolio
  24. 7.4.5 Sedico Recent Developments
  25. 7.5 Sanofi Aventis
  26. 7.5.1 Sanofi Aventis Company Information
  27. 7.5.2 Sanofi Aventis Business Overview
  28. 7.5.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Portfolio
  30. 7.5.5 Sanofi Aventis Recent Developments
  31. 7.6 Novo Nordisk
  32. 7.6.1 Novo Nordisk Company Information
  33. 7.6.2 Novo Nordisk Business Overview
  34. 7.6.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Portfolio
  36. 7.6.5 Novo Nordisk Recent Developments
  37. 7.7 Exir
  38. 7.7.1 Exir Company Information
  39. 7.7.2 Exir Business Overview
  40. 7.7.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Exir Basal Insulin (Long-Acting Insulin) Product Portfolio
  42. 7.7.5 Exir Recent Developments
  43. 7.8 Biocon
  44. 7.8.1 Biocon Company Information
  45. 7.8.2 Biocon Business Overview
  46. 7.8.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Biocon Basal Insulin (Long-Acting Insulin) Product Portfolio
  48. 7.8.5 Biocon Recent Developments
8 North America
  1. 8.1 North America Basal Insulin (Long-Acting Insulin) Market Size by Type
  2. 8.1.1 North America Basal Insulin (Long-Acting Insulin) Revenue by Type (2021-2032)
  3. 8.1.2 North America Basal Insulin (Long-Acting Insulin) Sales by Type (2021-2032)
  4. 8.1.3 North America Basal Insulin (Long-Acting Insulin) Price by Type (2021-2032)
  5. 8.2 North America Basal Insulin (Long-Acting Insulin) Market Size by Application
  6. 8.2.1 North America Basal Insulin (Long-Acting Insulin) Revenue by Application (2021-2032)
  7. 8.2.2 North America Basal Insulin (Long-Acting Insulin) Sales by Application (2021-2032)
  8. 8.2.3 North America Basal Insulin (Long-Acting Insulin) Price by Application (2021-2032)
  9. 8.3 North America Basal Insulin (Long-Acting Insulin) Market Size by Country
  10. 8.3.1 North America Basal Insulin (Long-Acting Insulin) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Basal Insulin (Long-Acting Insulin) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Basal Insulin (Long-Acting Insulin) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Basal Insulin (Long-Acting Insulin) Market Size by Type
  2. 9.1.1 Europe Basal Insulin (Long-Acting Insulin) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Basal Insulin (Long-Acting Insulin) Sales by Type (2021-2032)
  4. 9.1.3 Europe Basal Insulin (Long-Acting Insulin) Price by Type (2021-2032)
  5. 9.2 Europe Basal Insulin (Long-Acting Insulin) Market Size by Application
  6. 9.2.1 Europe Basal Insulin (Long-Acting Insulin) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2021-2032)
  8. 9.2.3 Europe Basal Insulin (Long-Acting Insulin) Price by Application (2021-2032)
  9. 9.3 Europe Basal Insulin (Long-Acting Insulin) Market Size by Country
  10. 9.3.1 Europe Basal Insulin (Long-Acting Insulin) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Basal Insulin (Long-Acting Insulin) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Basal Insulin (Long-Acting Insulin) Market Size by Type
  2. 10.1.1 China Basal Insulin (Long-Acting Insulin) Revenue by Type (2021-2032)
  3. 10.1.2 China Basal Insulin (Long-Acting Insulin) Sales by Type (2021-2032)
  4. 10.1.3 China Basal Insulin (Long-Acting Insulin) Price by Type (2021-2032)
  5. 10.2 China Basal Insulin (Long-Acting Insulin) Market Size by Application
  6. 10.2.1 China Basal Insulin (Long-Acting Insulin) Revenue by Application (2021-2032)
  7. 10.2.2 China Basal Insulin (Long-Acting Insulin) Sales by Application (2021-2032)
  8. 10.2.3 China Basal Insulin (Long-Acting Insulin) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Basal Insulin (Long-Acting Insulin) Market Size by Type
  2. 11.1.1 Asia Basal Insulin (Long-Acting Insulin) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Basal Insulin (Long-Acting Insulin) Sales by Type (2021-2032)
  4. 11.1.3 Asia Basal Insulin (Long-Acting Insulin) Price by Type (2021-2032)
  5. 11.2 Asia Basal Insulin (Long-Acting Insulin) Market Size by Application
  6. 11.2.1 Asia Basal Insulin (Long-Acting Insulin) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Basal Insulin (Long-Acting Insulin) Sales by Application (2021-2032)
  8. 11.2.3 Asia Basal Insulin (Long-Acting Insulin) Price by Application (2021-2032)
  9. 11.3 Asia Basal Insulin (Long-Acting Insulin) Market Size by Country
  10. 11.3.1 Asia Basal Insulin (Long-Acting Insulin) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Basal Insulin (Long-Acting Insulin) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Basal Insulin (Long-Acting Insulin) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Basal Insulin (Long-Acting Insulin) Market Size by Type
  2. 12.1.1 SAMEA Basal Insulin (Long-Acting Insulin) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Basal Insulin (Long-Acting Insulin) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Basal Insulin (Long-Acting Insulin) Price by Type (2021-2032)
  5. 12.2 SAMEA Basal Insulin (Long-Acting Insulin) Market Size by Application
  6. 12.2.1 SAMEA Basal Insulin (Long-Acting Insulin) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Basal Insulin (Long-Acting Insulin) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Basal Insulin (Long-Acting Insulin) Price by Application (2021-2032)
  9. 12.3 SAMEA Basal Insulin (Long-Acting Insulin) Market Size by Country
  10. 12.3.1 SAMEA Basal Insulin (Long-Acting Insulin) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Basal Insulin (Long-Acting Insulin) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Basal Insulin (Long-Acting Insulin) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Basal Insulin (Long-Acting Insulin) Value Chain Analysis
  2. 13.1.1 Basal Insulin (Long-Acting Insulin) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Basal Insulin (Long-Acting Insulin) Production Mode & Process
  6. 13.2 Basal Insulin (Long-Acting Insulin) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Basal Insulin (Long-Acting Insulin) Distributors
  9. 13.2.3 Basal Insulin (Long-Acting Insulin) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst